2023
DOI: 10.1016/j.advms.2023.10.001
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells

Shan Jin,
Hong Yong,
Yousheng Liu
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Recent research has utilized CRISPR/Cas9 technology to knockout or knockdown various functional genes, aiding researchers in comprehending their cellular level functions across diverse metabolisms, pathways, and biological processes. Jin et al [17] used the CRISPR/Cas9 system to establish a HMGA2 knockout PTC cell line in order to exploring the HMGA2 effect on PTC cell proliferation and invasion. A Cluster of differentiation 16 α (CD16A) knockout human embryonic stem (hESC) cell line was constructed and was used to investigate the role of CD16A in the human cell development [18].…”
Section: Discussionmentioning
confidence: 99%
“…Recent research has utilized CRISPR/Cas9 technology to knockout or knockdown various functional genes, aiding researchers in comprehending their cellular level functions across diverse metabolisms, pathways, and biological processes. Jin et al [17] used the CRISPR/Cas9 system to establish a HMGA2 knockout PTC cell line in order to exploring the HMGA2 effect on PTC cell proliferation and invasion. A Cluster of differentiation 16 α (CD16A) knockout human embryonic stem (hESC) cell line was constructed and was used to investigate the role of CD16A in the human cell development [18].…”
Section: Discussionmentioning
confidence: 99%
“…The use of the CRISPR/Cas9 system for targeted gene therapy against tumors has been widely reported. In doxorubicin-resistant BC cells, flow cytometric analysis showed that targeting MDR1 using the CRISPR/Cas9 system increased drug accumulation within the cell compared with untreated cells ( 135 ). Song et al.…”
Section: Gene Therapy Methodsmentioning
confidence: 99%
“…In addition, in papillary thyroid carcinoma cells, the CRISPR/Cas9-mediated knockout of HMGA2 inhibited cell proliferation and invasion. It was suggested that HMGA2 knockout blocked the cell cycle in the G2/M phase and promoted cell necrosis ( 135 ). The results mentioned above showed that targeting HMGA2 using CRISPR/Cas9 technology can reduce drug resistance in cancers.…”
Section: Gene Therapy Methodsmentioning
confidence: 99%